Aimed at exploring all aspects of the translational research continuum, from early detection through treatment to survivorship, this special 5-day Eurocanplatform Translational Cancer Research Course, 20 – 24 October 2014, Algarve, Portugal, will provide unparalleled educational opportunity to interact and exchange with an expert international cast of speakers. The meeting, organized through EurocanPlatform´s WP13 Education & Training, will culminate in a final day workshop focusing on precision medicine in oncology.
Scientific Committee:
René Bernards, Anne-Lise Børresen-Dale, Carlos Caldas, José Moreira, Angelo Paradiso, and Ulrik Ringborg.
Program:
Day 1: Overview/ Innovative Aspects in Cancer Biology
Day 2: Research areas driving preventive & clinical research
Day 3: Bridging preclinical & preventive/ clinical research
Day 4: Clinical & late translational cancer research
Day 5: Clinical Personalised Medicine Workshop
Participation is limited to 100 individuals, the majority of whom will be young scientists (PhD, MD/PhD, post-doctoral fellows) are specifically encouraged to apply.
PLEASE NOTE: application closes 04 August 2014.
To discover more, view the Teaching Faculty, and apply today visit: www.eurocanplatform.eu.
About EurocanPlatform:
Funded by the European Commission’s 7th Framework Programme, Eurocanplatform is a pioneering project led by The Karolinska Institute comprising 28 European leading cancer Institutions and organizations, including VHIO. Sharing infrastructures and co-collaborating in various projects, such a unique, collective effort en force, will ultimately contribute to advancing cancer research & treatment, improving outcomes for cancer patients, and reducing mortality Europe-wide.
